MedPath

International Collaborative Ovarian Neoplasm studies (1): A trial of adjuvant chemotherapy for early stage ovarian cancer

Completed
Conditions
Cancer
Ovarian
Registration Number
ISRCTN11916376
Lead Sponsor
Medical Research Council (MRC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
2000
Inclusion Criteria

1. Chemotherapy not clearly indicated
2. No previous malignancy
3. No prior radiotherapy or chemotherapy
4. No contraindication to chemotherapy

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survival time; recurrence-free survival.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath